Genenta Science S.p.A (GNTA) Liabilities and Shareholders Equity (2020 - 2025)

Genenta Science S.p.A has reported Liabilities and Shareholders Equity for 6 years, with the latest figure at $37.1 million in Q4 2025.

• Quarterly Liabilities and Shareholders Equity rose 134.33% year-over-year to $37.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $97.8 million (up 9.36% YoY) and the FY2025 annual result came in at $37.1 million, up 134.33% from the prior year.
• Liabilities and Shareholders Equity improved to $37.1 million in Q4 2025 per GNTA's latest filing, from $24.4 million in the prior quarter.
• Over five years, Liabilities and Shareholders Equity peaked at $45.8 million in Q4 2021 and troughed at $15.8 million in Q4 2024.
• A 5-year average of $30.2 million and a median of $29.1 million in 2023 frame the typical range for Liabilities and Shareholders Equity.
• The sharpest annual moves came in 2024 and 2025: Liabilities and Shareholders Equity plunged 34.12% in 2024, then soared 134.33% in 2025.
• Over 5 years, Liabilities and Shareholders Equity stood at $45.8 million in 2021, then fell by 25.5% to $34.1 million in 2022, then fell by 29.52% to $24.0 million in 2023, then slumped by 34.12% to $15.8 million in 2024, then jumped by 134.33% to $37.1 million in 2025.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $37.1 million, $24.4 million, and $15.8 million for Q4 2025, Q2 2025, and Q4 2024 respectively.